Education
About Us
Working with TipRanks
Follow Us
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 3.09M | $ 1.53M | $ 1.00M | $ 1.02M | - |
| Operating Income | $ -29.99M | $ -42.71M | $ -22.40M | $ -29.09M | $ -26.87M |
| EBITDA | $ -29.51M | $ -42.28M | $ -22.06M | $ -29.34M | $ -21.82M |
| Net Income | $ -30.37M | $ -42.19M | $ -22.33M | $ -29.68M | $ -22.11M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 14.70M | $ 28.70M | $ 15.12M | $ 27.97M | $ 31.61M |
| Total Debt | $ 6.13M | $ 5.98M | $ 715.00K | $ 0.00 | $ 0.00 |
| Net Debt | $ 1.25M | $ -12.12M | $ -7.52M | $ -20.90M | $ -24.24M |
| Total Liabilities | $ 38.93M | $ 39.91M | $ 23.80M | $ 24.33M | $ 5.30M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -29.21M | $ -23.47M | $ -20.84M | $ -8.33M | $ -25.31M |
| Operating Cash Flow | $ -29.13M | $ -22.94M | $ -20.48M | $ -8.16M | $ -24.31M |
| Investing Cash Flow | |||||
| Financing Cash Flow |